
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $396.1M | -- | -- | $0.31 | -- |
07/31/2025 | Q2 | $393.8M | -- | -- | $0.33 | -- |
05/02/2025 | Q1 | $388.9M | $390.6M | $0.36 | $0.28 | $0.08 |
02/06/2025 | Q4 | $386.2M | $386.3M | $0.37 | $0.42 | -$0.05 |
10/31/2024 | Q3 | $389.4M | $387.2M | -$0.04 | $0.28 | -$0.32 |
08/01/2024 | Q2 | $385.4M | $387.2M | $0.40 | $0.37 | $0.03 |
05/02/2024 | Q1 | $385.8M | $383.1M | $0.77 | $0.36 | $0.41 |
02/01/2024 | Q4 | $387.3M | $387.6M | $2.03 | $0.42 | $1.61 |
10/26/2023 | Q3 | $390.9M | $390.8M | $0.44 | $0.39 | $0.05 |
08/03/2023 | Q2 | $383.9M | $385.5M | $0.84 | $0.34 | $0.50 |
04/27/2023 | Q1 | -- | $378.2M | $0.39 | -- | -- |
02/02/2023 | Q4 | -- | $375.9M | $0.42 | -- | -- |
10/27/2022 | Q3 | -- | $373.8M | $0.27 | -- | -- |
07/28/2022 | Q2 | -- | $361.7M | $4.54 | -- | -- |
04/28/2022 | Q1 | -- | $311.4M | $0.76 | -- | -- |
02/03/2022 | Q4 | -- | $305.4M | $2.02 | -- | -- |
10/28/2021 | Q3 | -- | $294.1M | $0.29 | -- | -- |
07/29/2021 | Q2 | -- | $276.5M | $0.30 | -- | -- |
04/29/2021 | Q1 | -- | $267.6M | $0.31 | -- | -- |
02/04/2021 | Q4 | -- | $261.6M | $0.29 | -- | -- |
10/29/2020 | Q3 | -- | $265.7M | $0.35 | -- | -- |
07/30/2020 | Q2 | -- | $250.7M | $0.17 | -- | -- |
05/07/2020 | Q1 | -- | $265.9M | $0.43 | -- | -- |
01/30/2020 | Q4 | -- | $263.5M | $0.95 | -- | -- |
10/31/2019 | Q3 | -- | $260.7M | $0.44 | -- | -- |
07/25/2019 | Q2 | -- | $255.8M | $0.43 | -- | -- |
05/02/2019 | Q1 | -- | $248.6M | $0.40 | -- | -- |
01/31/2019 | Q4 | -- | $244.9M | $0.41 | -- | -- |
10/25/2018 | Q3 | -- | $241.8M | $0.40 | -- | -- |
08/02/2018 | Q2 | -- | $237.1M | $0.40 | -- | -- |
05/03/2018 | Q1 | -- | $230.7M | $0.41 | -- | -- |
02/01/2018 | Q4 | -- | $229.8M | $0.91 | -- | -- |
10/26/2017 | Q3 | -- | $228.2M | $0.38 | -- | -- |
07/27/2017 | Q2 | -- | $223.4M | $0.43 | -- | -- |
05/04/2017 | Q1 | -- | $219.5M | $0.39 | -- | -- |
02/07/2017 | Q4 | -- | $217.1M | $0.45 | -- | -- |
10/28/2016 | Q3 | -- | $220.2M | $3.21 | -- | -- |
07/28/2016 | Q2 | -- | $221.5M | $4.92 | -- | -- |
04/29/2016 | Q1 | -- | $217.6M | $0.46 | -- | -- |
01/28/2016 | Q4 | -- | $215M | $0.67 | -- | -- |
10/30/2015 | Q3 | -- | $212.6M | $0.41 | -- | -- |
Camden Property Trust reported $390.6M worth of top line sales in its most recent quarter.
Camden Property Trust announced earnings per share of $0.36 which represents a beat of analyst forecast a $0.28 per share.
Camden Property Trust reported $240.6M that represents $2.22 per share over the last quarter.
Camden Property Trust's earnings are forecast to decrease from $1.50 per share to $1.80 per share next year representing a decrease of -21.75%.
Camden Property Trust's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.